Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept for prevention of rheumatoid arthritis in high-risk arthralgia
NL-OMON47610Phase 2Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Nov 2017
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial in rheumatoid arthritis (RA) comparing Abatacept with Placebo (2 arms). Primary endpoint: Time to development of clinical synovitis or rheumatoid arthritis. Started Nov 2017; status: active, not recruiting.
02
Drugs
abatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON47610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47610.